Skip to content

Vitor Breseghello Cavenaghi

2 papers in the library · 40 citations · publishing 2022-2025

Papers

Sort Most recent Most cited

Long-Term Cognitive Outcomes of Esketamine Nasal Spray in Treatment-Resistant Depression: A Preliminary Report.

Pharmaceuticals (Basel, Switzerland) January 27, 2025 Matildes de Freitas Menezes Sobreiro, Paulo Sergio Panse Silveira, Vitor Breseghello Cavenaghi et al. 5 citations

Background/Objectives: Ketamine/esketamine has a rapid/robust antidepressant effect on treatment-resistant depression (TRD). However, its long-term cognitive effects remain unclear. In this study, we investigated the potential cognitive effects of an esketamine spray on a series of TRD patients. Methods: We evaluated the cognitive performance of eight TRD patients subjected to an esketamine...

Ketamine in the Treatment of Obsessive-Compulsive Disorder: A Systematic Review

Harvard Review of Psychiatry March 1, 2022 Igor D. Bandeira, Daniel H Lins-Silva, Vitor Breseghello Cavenaghi et al. 35 citations

INTRODUCTION: First-line treatment for obsessive-compulsive disorder (OCD) includes exposure and response prevention behavioral therapy and serotonin reuptake inhibitors, particularly in combination. New and more effective treatments are needed, give that recent studies suggest that glutamatergic neurotransmission contributes to the pathophysiology of the disorder. In these circumstances,...